Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 19 | Showing Results 1 - 5 of 95

YO39523/GOG-3015: A Phase III, Multicenter, Randomized Study of Atezolizumab Versus Placebo Administered in Combination with Paclitaxel, Carboplatin, and Bevacizumab for Patients with Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

This is a Phase III, global, double-blind, 2-arm randomized study designed to compare the efficacy and safety of atezolizumab + paclitaxel +...

Tariq Mahmood, M.D.
  • SJH Southern California
  • St. Joseph Hospital of Orange

A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy in the Treatment of Patients of Patients with HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment

Inclusion Criteria: Histologically-proven metastatic or locally-advanced relapsed/refractory HER2+ breast cancer based on the most recently...

Raul Mena, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center

Single fraction Intraoperative Radiotherapy with Electrons an Option in Breast-Conserving Treatment for Operated Breast Cancer Stages 0, I and II

The purpose of this study is to assess the radiation toxicity (acute and late) for all women treated with Intraoperative radiotherapy (IORT).

Robert Ash, M.D.
  • SJH Southern California
  • St. Joseph Hospital of Orange

I3Y-MC-JPCF/B-58A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

The purpose of the study is to determine if administration of the investigational drug, abemaciclib, in addition to adjuvant endocrine therapy...

Stavroula Otis, M.D.
  • SJH Southern California

A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

This randomized phase III trial studies how well aspirin works in preventing the cancer from coming back (recurrence) in patients with human...

Timothy Byun, M.D.
  • SJH Southern California
  • St. Joseph Hospital of Orange
« Previous 12345 Next »
Viewing Page 1 of 19 | Showing Results 1 - 5 of 95